SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-122502
Filing Date
2019-04-26
Accepted
2019-04-26 16:39:55
Documents
10
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d736507ddefa14a.htm DEFA14A 26343
2 GRAPHIC g736507dsp02a.jpg GRAPHIC 6861
3 GRAPHIC g736507dsp02b.jpg GRAPHIC 1223
4 GRAPHIC g736507dsp02c.jpg GRAPHIC 7189
5 GRAPHIC g736507dsp02d.jpg GRAPHIC 5616
6 GRAPHIC g736507dsp02e.jpg GRAPHIC 1526
7 GRAPHIC g736507dsp02f.jpg GRAPHIC 1291
8 GRAPHIC g736507dsp02g.jpg GRAPHIC 2092
9 GRAPHIC g736507dsp03a.jpg GRAPHIC 5232
10 GRAPHIC g736507dsp03b.jpg GRAPHIC 1307
  Complete submission text file 0001193125-19-122502.txt   73470
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14895 | Film No.: 19772253
SIC: 2834 Pharmaceutical Preparations